In recent years, particularly accelerated by the COVID-19 pandemic, the relationship between pharmaceutical companies and payers has become crucial for improving patient outcomes, controlling healthcare costs, and driving innovation.

As the industry grapples with the complexities of drug pricing, data integration, and the role of digital technology, there is a growing need for a more collaborative approach.